Journal Article

DKFZ-2021-01378

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy

Bahrololoumi Shapourabadi, M. ; Momburg, F.DKFZ* ; Roohvand, F. ; Jarahian, M.DKFZ* ; Mohajel, N. ; Arashkia, A. ; Hajari Taheri, F. ; Abbasalipour, M. ; Azadmanesh, K.

2021
Elsevier Science Amsterdam [u.a.]

This record in other databases:  

Please use a persistent id in citations: doi:10.1016/j.intimp.2021.107762

---

Contributing Institute(s):

1. D121 AG Antigenpräsentation und T/NK-Zell-Aktivierung (D121)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2021

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---